NEW
YORK, June 19, 2024 /PRNewswire/ -- The
global bacterial disease diagnostics market size is
estimated to grow by USD
4.34 billion from 2024-2028, according to Technavio.
The market is estimated to grow at a CAGR of 6.78%
during the forecast period. Integration of digital
health in rapid diagnostics for bacterial disease is driving
market growth, with a trend towards growing demand for
portable analytical instruments. However, limitations of
electrophoresis systems poses a challenge. Key market players
include Abbott Laboratories, Accelerate Diagnostics Inc.,
Becton Dickinson and Co., Bio Rad
Laboratories Inc., bioMerieux SA, Bruker Corp., Danaher Corp.,
DiaSorin SpA, EKF Diagnostics Holdings Plc, F. Hoffmann La Roche
Ltd., GENERI BIOTECH s.r.o., Great Basin Scientific, Hologic Inc.,
Meridian Bioscience Inc., QIAGEN NV, Quest Diagnostics Inc.,
Revvity Inc., Siemens AG, T2 Biosystems Inc., and Takara Bio
Inc..
![Technavio has announced its latest market research report titled Global bacterial disease diagnostics market 2024-2028 Technavio has announced its latest market research report titled Global bacterial disease diagnostics market 2024-2028](https://mma.prnewswire.com/media/2441493/Global_bacterial_disease_diagnostics_market_Infographic.jpg)
Get a detailed analysis on regions, market
segments, customer landscape, and companies - Click for the
snapshot of this report
Forecast
period
|
2024-2028
|
Base Year
|
2023
|
Historic
Data
|
2018 - 2022
|
Segment
Covered
|
Product (Consumables
and Instruments), End-user (Hospitals and Labs), and Geography
(North America, Europe, Asia, and Rest of World (ROW))
|
Region
Covered
|
North America, Europe,
Asia, and Rest of World (ROW)
|
Key companies
profiled
|
Abbott Laboratories,
Accelerate Diagnostics Inc., Becton Dickinson and Co., Bio Rad
Laboratories Inc., bioMerieux SA, Bruker Corp., Danaher Corp.,
DiaSorin SpA, EKF Diagnostics Holdings Plc, F. Hoffmann La Roche
Ltd., GENERI BIOTECH s.r.o., Great Basin Scientific, Hologic Inc.,
Meridian Bioscience Inc., QIAGEN NV, Quest Diagnostics Inc.,
Revvity Inc., Siemens AG, T2 Biosystems Inc., and Takara Bio
Inc.
|
Key Market Trends Fueling Growth
Portable laboratory instruments are revolutionizing the
bacterial disease diagnostics market due to their convenience and
real-time capabilities. These devices enable on-site analysis of
samples, providing immediate results for health and safety
concerns. Portable PCR systems, like the CFX384 Real-Time PCR
Detection System by Bio-Rad Laboratories, offer precise
quantitation and target differentiation with factory calibration
for efficiency. These instruments enable rapid and accurate
diagnosis of bacterial infections and detection of
antibiotic-resistant strains, contributing significantly to market
growth.
The Bacterial Disease Diagnostics market is experiencing
significant growth due to the increasing incidence of bacterial
infections and the need for accurate and timely diagnosis.
Fundamental diagnostic techniques such as culture-based methods and
microscopy continue to be used, but advanced technologies like PCR
and molecular diagnostics are gaining popularity. Infectious
diseases like Tuberculosis, Hepatitis C, and HIV require specific
diagnostic tests. The use of next-generation sequencing technology
is also on the rise, enabling the identification of multiple
pathogens in a single sample. The market is driven by factors such
as increasing government funding, rising healthcare expenditures,
and the growing awareness of the importance of early and accurate
diagnosis. The market is expected to continue its growth trajectory
in the coming years.
Research report provides comprehensive data on
impact of trend. For more details- Download a Sample
Report
Market Challenges
- The bacterial disease diagnostics market relies heavily on
techniques like gel electrophoresis for macromolecule analysis.
However, electrophoresis systems have limitations. They can only
separate proteins, DNA, and RNA, and their resolving power is
limited. Precision and reproducibility are also challenges due to
variables like equipment consistency and water quality. 2D gel
electrophoresis is complex and time-consuming. Mass spectrometry
compatibility is another hurdle due to the difficulty of removing
macromolecules from gels for analysis. These limitations may
restrict market growth during the forecast period.
- The Bacterial Disease Diagnostics market faces several
challenges in providing accurate and timely results. One major
challenge is the diversity of bacterial strains and their ability
to develop antibiotic resistance. This requires continuous
development of new diagnostic methods and technologies. Another
challenge is the need for rapid and point-of-care testing to
improve patient outcomes and reduce healthcare costs. Additionally,
regulatory requirements and reimbursement policies can hinder
market growth. Furthermore, the high cost of advanced diagnostic
technologies and the need for skilled personnel to operate them can
limit market accessibility. Lastly, the lack of standardization in
diagnostic methods and data reporting can hinder market development
and hinder comparability of results across different
laboratories.
For more insights on driver and
challenges - Download a Sample Report
Segment Overview
This bacterial disease diagnostics market report extensively
covers market segmentation by
- Product
- 1.1 Consumables
- 1.2 Instruments
- End-user
- Geography
- 3.1 North America
- 3.2 Europe
- 3.3 Asia
- 3.4 Rest of World (ROW)
1.1 Consumables- The consumables segment, including
test kits, assays, and reagents, plays a crucial role in the
bacterial disease diagnostics market. Repeated purchases for
various testing purposes drive market growth. Technological
advances in reaction buffers and microarray enhance the value of
PCR and RT-PCR techniques. Shifting diagnostic testing to home
settings increases demand for consumables. In developing countries,
improving rural healthcare facilities also boosts demand. Overall,
the consumables segment's growth is attributed to technological
advances, increasing applications, and repeated purchases.
For more information on market segmentation with
geographical analysis including forecast (2024-2028) and historic
data (2018 - 2022) - Download a Sample Report
Research Analysis
The Bacterial Disease Diagnostics market encompasses various
schemes and funding opportunities aimed at advancing research and
innovation in disease detection and monitoring. Financial
incentives are provided through grants like the CONNECT-C Grant
Program, which supports initiatives in infectious diseases and
molecular methods, including PCR and electron microscopy.
Infrastructure development is crucial for the implementation of
these advanced diagnostic techniques, with companies like Biogenuix
and Auro Biotechnologies contributing to the production of
essential reagents and equipment. Personalized medicine approaches
are also gaining traction in bacterial disease diagnostics,
challenging previous assumptions about one-size-fits-all
treatments. Torus Biosystems and Omega Specialty Nurses are among
the organizations focusing on RNA disease diagnostics, while House
of Sophrosyne and Thermo Fisher Scientific are involved in the
development and application of molecular and logistic methods.
Aquaculture industries, particularly those focusing on carp and
mackerel, can benefit significantly from these advancements in
bacterial disease diagnostics.
Market Research Overview
The Bacterial Disease Diagnostics Market encompasses innovative
technologies and techniques for the identification and detection of
bacterial infections. This market caters to the growing demand for
accurate and timely diagnosis of bacterial diseases, enabling
effective treatment and prevention of complications. Infectious
diseases caused by bacteria pose a significant global health
burden, necessitating the development of advanced diagnostic
solutions. Technologies such as Polymerase Chain Reaction (PCR),
Mass Spectrometry, and Immunoassays are driving the growth of the
Bacterial Disease Diagnostics Market. Additionally, the increasing
prevalence of antibiotic resistance and the need for rapid and
point-of-care testing are further fueling market expansion. The
market is segmented based on technology, application, and
end-user.
Table of Contents:
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation
- Product
-
- End-user
-
- Geography
-
- North America
- Europe
- Asia
- Rest Of World (ROW)
7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Trends
10 Company Landscape
11 Company Analysis
12 Appendix
About Technavio
Technavio is a leading global technology research and advisory
company. Their research and analysis focuses on emerging market
trends and provides actionable insights to help businesses identify
market opportunities and develop effective strategies to optimize
their market positions.
With over 500 specialized analysts, Technavio's report library
consists of more than 17,000 reports and counting, covering 800
technologies, spanning across 50 countries. Their client base
consists of enterprises of all sizes, including more than 100
Fortune 500 companies. This growing client base relies on
Technavio's comprehensive coverage, extensive research, and
actionable market insights to identify opportunities in existing
and potential markets and assess their competitive positions within
changing market scenarios.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
View original content to download
multimedia:https://www.prnewswire.com/news-releases/bacterial-disease-diagnostics-market-size-is-set-to-grow-by-usd-4-34-billion-from-2024-2028--integration-of-digital-health-in-rapid-diagnostics-for-bacterial-disease-to-boost-the-market-growth-technavio-302176390.html
SOURCE Technavio